Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl

Refine search results

Journals help
Years help
Authors help
Preferences help
enabled [disable] Abstract
Number of results

Results found: 11

Number of results on page
first rewind previous Page / 1 next fast forward last

Search results

Search:
in the keywords:  survival
help Sort By:

help Limit search:
first rewind previous Page / 1 next fast forward last
EN
INTRODUCTION: Cardiovascular diseases, including coronary disease and its complications, are the most common cause of death. Myocardial infarction is usually caused by a blood clot cosing the lumen of a coronary artery at the site of an unstable atherosclerotic plaque. MATERIAL AND METHODS: All the analyzed patients with mechanical complications of acute myocardial infarction (AMI) were hospitalized at the 2nd Department of Cardiology and Department of Anaesthesiology and Intensive Care of the Upper-Silesian Medical Centre in Katowice in 2006–2016 and the database was based on the medical records of the patients. The study group comprised 52 (100%) patients. There were 23 (44.2%) women and 29 (55.8%) men, aged 54 to 84 years with a mean age of 69.8 years. RESULTS: Ventricular septal rupture (n = 36; 69.2%) was the most frequently observed complication but papillary muscle rupture (n = 4; 7.7%) and tendinous chord rupture (n = 4; 7.7%) were the least frequent. Hypertension and hypercholesterolemia were the most common risk factors for coronary heart disease in the study group. An increased mortality rate was observed in patients who received pharmacological treatment compared to surgically treated patients (87.5% vs. 61.4%). The majority of patients had one risk factor for coronary heart disease (28; 53.8%). CONCLUSIONS: 1. In the study group, ventricular septal rupture and the cardiac free wall rupture were the most frequently observed mechanical complications of AMI. 2. Patients with AMI had numerous risk factors for coronary heart disease, of which hypertension and hypercholesterolemia were the most common. 3. Patients with mechanical complications of AMI had both higher mortality rates than survival and they were higher in the pharmacologically treated group.
PL
WSTĘP: Choroby układu krążenia, w tym choroba wieńcowa i jej powikłania, stanowią najczęstszą przyczynę zgonów. Zawał mięśnia sercowego spowodowany jest zwykle pęknięciem blaszki miażdżycowej i zamknięciem tętnicy wieńcowej skrzepliną. MATERIAŁ I METODY: Badaniem objęto 52 chorych (100%) z mechanicznymi powikłaniami ostrego zawału serca, hospitalizowanych w II Oddziale Kardiologii oraz Oddziale Anestezjologii i Intensywnej Terapii Górnośląskiego Centrum Medycznego w Katowicach w latach 2006–2016, wtym 23 kobiety (44,2%) i 29 mężczyzn (55,8%) w wieku 54‒84 lat (średnia wieku 69,8 roku). WYNIKI: Najczęstszym powikłaniem było pęknięcie przegrody międzykomorowej (n = 36; 69,2%), natomiast do najrzadszych należały pęknięcie mięśnia brodawkowatego (n = 4; 7,7%) i pęknięcie ścięgien (n = 4; 7,7%). Nadciśnienie i hipercholesterolemia były najczęstszymi czynnikami ryzyka wystąpienia choroby niedokrwiennej serca w badanej grupie. Zwiększoną śmiertelność zaobserwowano u pacjentów leczonych farmakologicznie (87,5%), podczas gdy śmiertelność pacjentów leczonych operacyjnie wynosiła 61,4%. U większości pacjentów występował jeden czynnik ryzyka choroby wieńcowej (n = 28; 53,8%). WNIOSKI: 1. Najczęstszymi powikłaniami były pęknięcie przegrody międzykomorowej i pęknięcie ściany serca. 2. U pacjentów występowało wiele czynników ryzyka dla choroby niedokrwiennej serca, spośród których najczęstszymi były nadciśnienie i hipercholesterolemia. 3. Śmiertelność w badanej grupie chorych z mechanicznymi powikłaniami ostrego zawału serca znacznie przewyższała przeżywalność i była większa w grupie leczonych zachowawczo.
EN
The aim of the study was to analyse liver transplantation results in patients with hepatocellular carcinoma, considering selected factors.Material and methods. The study group comprised 82 patients subject to liver transplantation at the Department of General, Transplant and Liver Surgery, Warsaw Medical University, due to hepatocellular carcinoma. Retrospective analysis concerned the period between 2001 and 2010. Distant survival results were evaluated, depending on whether Milan criteria were fulfilled, and the preoperative level of alpha-fetoprotein estimated. The obtained results were subject to statistical analysis. p<0.05 was considered as statistically significant.Results. Mean survival time considering patients subject to liver transplantation, due to hepatocellular carcinoma amounted to 66.7 months (95% PU 58.9-74.4), while survival without tumor recurrence - 62.3 months (95% PU 54-70.6). The one, three and five - year survival rate was 88.7%, 74.8% and 72.0%, respectively. Survival without tumor recurrence was 87.5%, 67.1% and 67.1%, respectively. The overall survival of patients fulfilling the Milan criteria (44 of 82 patients - 53.7%) was significantly longer, in comparison to patients not fulfilling the above-mentioned (74.4 and 48.3 months, respectively, p=0.025). A significant difference was also observed, considering the overall survival in the absence of cancer recurrence (72.5 and 42.4 months, respectively, p=0.007). Considering patients not fulfilling the Milan criteria who presented with preoperative alpha-fetoprotein levels > 100 ng/ml, overall survival was shorter, as compared to the mean survival rate: 32.5 and 64.4 months, respectively, p = 0.009. Similar values were obtained in case of patients without tumor recurrence (27 and 57.1 months, p=0.011).Conclusions. The obtained results confirmed the significant value of Milan criteria, when qualifying patients with hepatocellular carcinoma for liver transplantation. The above-mentioned also showed the potential value of preoperative alpha-fetoprotein level measurements, not only in the diagnostics and early hepatocellular carcinoma diagnosis (patients with cirrhosis), but also in the prediction of survival and tumor recurrence after liver transplantation.
EN
Background. Tunneled catheters are becoming increasingly used as a permanent dialysis access. Easy way of insertion and good long-term patency make them competitive to fistulas in some groups of patients. Methods. Late complications and survival of 180 tunneled catheters inserted from June 2010 to December 2013 in 171 unselected hemodialysis patients were analyzed. Results. The cumulative time of observation was 2103.5 patient-months and median observation was 9 months (range of 0.5-45 months). Only 19 out of 180 catheters were removed due to complications (12 for infections, 4 due to malfunction and 3 because of mechanical damage). Majority of catheters were removed electively: 27 after maturation of arterio-venous fistula (AVF), 4 after kidney transplant, 5 after transfer to peritoneal dialysis and 3 due to the recovery of renal function. At the end of the observation, 58 catheters were still in use and 64 patients had died with functioning catheter. When censored for elective catheter removal and patient death, 88.2% of catheters survived for 1 year. Catheter survival was significantly better in older patients (over 65 years, in comparison to patients < 65 years, p = 0.046). Conclusions. Nearly 90% of all inserted catheters gave reliable dialysis access as long as it was needed. Among them, over 30% of the inserted catheters were in use at the end of the observation period, and over 30% of patients had died with a functioning catheter. The results of tunneled catheters survival are encouraging and they should be taken into consideration during decision-making on vascular access, especially in the older patients.
EN
Dioscin is a natural steroidal saponin mainly exacted from Dioscoreae Rhizoma, which usually used as traditional medicine in east asia area. Dioscin has various pharmacological actions. However, little is known concerning the role on Lipopolysaccharide (LPS)-induced endotoxemia. The aim of the present study was to investigate the effects and possible mechanisms of dioscin against LPS-induced endotoxemia in mice. The data showed dioscin significantly increased mouse survival when mice were treated with dioscin prior to or after LPS challenge and significantly attenuated TNF-α, IL-1β and IL-6 production in serum. Further studies revealed that dioscin could downregulate LPS-induced nuclear transcription factor - қB (NF-қB) signal transduction pathways. These observations indicated that dioscin modulated early cytokine responses by blocking NF-қB activation, and thus, increased mouse survival in murine endotoxemia induced by LPS.
EN
The aim of the study was to evaluate the influence of the surgeons' caseload on the results of therapy in rectal cancer.Material and methods. 286 consecutive patients (155 males and 131 females) were enrolled and operated on for rectal cancer stage T2 (112 patients) and T3 (174 patients) in 8 surgical centers of Szczecin between January 1993 and December 1997. Studied group included about 79% of radically operated patients due were to rectal cancer in analyzed period.Results. The patients were assigned to one of two groups with regard to the surgeon's caseload. The first group was comprised of 116 patients (including 72 stage T3 and 54 stage T2 patients) operated on by surgeons more experienced in rectal surgery and the second group was comprised of 160 patients operated on by 36 surgeons with fewer caseloads. The surgeon's experience in rectal surgery was measured by the surgeon's caseload throughout the entire study period. We considered surgeons with greater than 25 cases over the study period experienced.Analysis of survival with regard to the managing center revealed significant differences for stage T3, with 5-year-survival rates ranging from 14% to 60%. Distinct differences were also noted for survival rates in stage T2 (5-year-survival rates ranged from 38% to 86%); however, these differences were not statistically significant. Analysis of the influence of surgeon's caseload on outcomes in rectal cancer revealed a significant influence in stage T3 and a lack of influence in stage T2.Conclusion. The surgeon's experience is an independent prognostic factor for stage T3 rectal cancer patients.
EN
Two molecules - vascular endothelial growth factor involved in new vessels formation and survivin - antiapoptotic protein, reported to be associated with worse prognosis in various malignancies have been chosen for the study. Both are potential target for novel therapiesThe aim of the study was to determine the immunostaining of VEGF and survivin in gastric carcinoma and to analyse their relationship to the selected clinicopathological features and survival.Material and methods. Formalin-fixed, paraffin-embedded sections from 41 gastric adenocarcinomas were used for immunohistochemical reaction with monoclonal antibodies against vascular endothelial growth factor and survivin. The results were compared with selected clinicopathological features and survival.Results. Positive immunohistochemical reaction for vascular endothelial growth factor and survivin was revealed in 24 (58,53%) and 30 (73,17%), gastric carcinomas respectively. Vascular endothelial growth factor-negative gastric carcinomas were significantly more common in cases without metastases to regional lymph nodes and distant organs and in less advanced cases. Similar, distant metastases were also statistically less common in survivin-negative carcinomas. The differences in immunohistochemical reactions for survivin between less and more advanced cases almost reach statistical significance. The only factors significantly influenced 1, 2 and 3-year survival were vascular endothelial growth factor and survivin status. Statistically significant higher percentage of survival was noted in patients with vascular endothelial growth factor- and survivin-negative tumors.Conclusions. It seems that vascular endothelial growth factor and survivin play role in local invasion and spread of gastric adenocarcinoma and negatively influences survival. However, further studies are required to assess their true usefulness in the clinical practice.
EN
Liver transplantation is a well-established treatment of patients with end-stage liver disease and selected liver tumors. Remarkable progress has been made over the last years concerning nearly all of its aspects. The aim of this study was to evaluate the evolution of long-term outcomes after liver transplantations performed in the Department of General, Transplant and Liver Surgery (Medical University of Warsaw). Material and methods. Data of 1500 liver transplantations performed between 1989 and 2014 were retrospectively analyzed. Transplantations were divided into 3 groups: group 1 including first 500 operations, group 2 including subsequent 500, and group 3 comprising the most recent 500. Five year overall and graft survival were set as outcome measures. Results. Increased number of transplantations performed at the site was associated with increased age of the recipients (p<0.001) and donors (p<0.001), increased rate of male recipients (p<0.001), and increased rate of piggyback operations (p<0.001), and decreased MELD (p<0.001), as well as decreased blood (p=0.006) and plasma (p<0.001) transfusions. Overall survival was 71.6% at 5 years in group 1, 74.5% at 5 years in group 2, and 85% at 2.9 years in group 3 (p=0.008). Improvement of overall survival was particularly observed for primary transplantations (p=0.004). Increased graft survival rates did not reach the level of significance (p=0.136). Conclusions. Long-term outcomes after liver transplantations performed in the Department of General, Transplant and Liver Surgery are comparable to those achieved in the largest transplant centers worldwide and are continuously improving despite increasing recipient age and wider utilization of organs procured from older donors.
EN
Introduction: Survival of patients with multiple sclerosis is a complex variable determined by several factors. Objective of the study was to ascertain the association between the level of hygiene well as regional mortality and survival of patients with multiple sclerosis. Study design: The study of relation between variables included 14,200 multiple sclerosis patients (male – 6,025, female – 8,175) who died in the period 1981–2010 in Poland. The average survival of male and female patients with multiple sclerosis correlated to the marker of hygiene level (the late mortality in infants rate per 1,000 live births) and average, annual, sex-adjusted mortality rates for multiple sclerosis in towns and in the countryside of Poland (1981–2010). All demographic data were obtained from the Central Statistical Office in Warsaw. Results: A longer survival of male and female patients with multiple sclerosis showed a significant correlation to a higher hygiene level in Poland: r = -0.867, r = -0.902, p = 0.0001. Sex-adjusted mortality rates for women with multiple sclerosis in towns and villages were much higher than the analogous rates for men with multiple sclerosis; p = 0.0001, p = 0.019. A longer duration of life in male and female patients with multiple sclerosis demonstrated a strong, inverse correlation to a lower mortality in the countryside: r = -0.803, r = -0.630, p = 0.0001. The survival of women with multiple sclerosis did not show correlation to sex-adjusted mortality rates in towns: r = -0.126, p = 0.90. Conclusions: The higher level of hygiene was associated with the longer survival of multiple sclerosis patients. The survival of male and female patients with multiple sclerosis showed an inverse correlation to the lower mortality in rural regions. The duration of life in women did not correlate to the higher mortality in towns.
PL
Wprowadzenie: Przeżycie chorych na stwardnienie rozsiane jest złożoną zmienną zależną od licznych czynników. Celem badania było stwierdzenie asocjacji między poziomem higieny oraz regionalną umieralnością i przeżyciem chorych na stwardnienie rozsiane. Metoda: Badanie relacji między zmiennymi objęło 14 200 chorych na stwardnienie rozsiane (mężczyźni – 6025, kobiety – 8175), którzy zmarli w latach 1981–2010 w Polsce. Przeciętne przeżycie mężczyzn i kobiet ze stwardnieniem rozsianym skorelowano z miernikiem poziomu higieny (współczynnikiem późnej umieralności niemowląt na 1000 żywych urodzeń) oraz z przeciętnymi, rocznymi, dostosowanymi do płci współczynnikami umieralności na stwardnienie rozsiane w miastach i na wsi Polski (1981–2010). Wszystkie dane demograficzne uzyskano z Głównego Urzędu Statystycznego w Warszawie. Wyniki: Dłuższe przeżycie mężczyzn i kobiet ze stwardnieniem rozsianym wykazało istotną korelację z wyższym poziomem higieny w Polsce: r = −0,867, r = −0,901, p = 0,0001. Dostosowane do płci współczynniki umieralności kobiet ze stwardnieniem rozsianym w miastach i na wsi były znamiennie wyższe niż analogiczne współczynniki u mężczyzn: p = 0,0001, p = 0,019. Dłuższe przeżycie mężczyzn i kobiet ze stwardnieniem rozsianym cechowało się mocną, odwróconą korelacją z niższą umieralnością na wsi: r = −0,803, r = −0,630, p = 0,0001. Długość życia kobiet nie korelowała z wyższą umieralnością w miastach: r = −0,126, p = 0,90. Wnioski: Im wyższy był poziom higieny, tym dłuższe było przeżycie chorych na stwardnienie rozsiane. Przeżycie mężczyzn i kobiet ze stwardnieniem rozsianym wykazało odwróconą korelację z niższą umieralnością na wsi. Długość życia kobiet nie korelowała z wyższą umieralnością w miastach.
EN
Crisis is a fact of life. It commonly means difficulties but it is also perceived as a breakthrough, beginning of changes. In order to fight against crisis one must be aware of danger. The more we know about a potential threat, the easier it is to get prepared for struggle. Knowledge lets us control the situation. Crisis intervention should mean a fast situation diagnosis (identification of the crisis causes), identification of the situation of the person in crisis and the ability to cope with problems, ability to cooperate and get help. A major part is played by a clinical psychologist or a psychologist representing holistic approaches. Prevention of specialized atomisation of medicine is often discussed and measures are taken against hindering of patients complex treatment. Health is perceived in the context of psychosocial factors, as every disease is accompanied by strong emotions dependent on many factors. Due to appropriate support, motivation and energy to fight against it can be released. The issue of crisis and struggle against it was not appreciated in the past, although crisis as a phenomenon present in the sphere of human activity is an inevitable consequence of the reality one lives in. Many factors determine how one fights against it, such as: individual reactions, environment, circumstances. The author would like the mentioned issues to be treated as a contribution to the discussion on the “humanization of the world”, which cannot be achieved without the participation of us, psychologists who are humanists.
PL
Kryzys to element życia. Potocznie oznacza trudności, ale postrzega się go także jako stan przełomu, początek zmian. Aby walczyć z kryzysem, trzeba mieć świadomość zagrożenia. Im więcej wiemy o potencjalnym zagrożeniu, tym łatwiej przygotować się do walki. Wiedza pozwala na kontrolowanie sytuacji. Interwencja kryzysowa powinna polegać na szybkim zdiagnozowaniu sytuacji (identyfikacji przyczyn kryzysu), określeniu sytuacji osoby w kryzysie i jej umiejętności poradzenia sobie z problemami, możliwości współdziałania, a także udzieleniu pomocy. Istotną rolę odgrywa tu psycholog lub psycholog kliniczny, reprezentujący holistyczne podejście. Coraz częściej mówi się o zapobieganiu specjalistycznej atomizacji medycyny i podejmuje kroki zapobiegające hamowaniu kompleksowego leczenia pacjenta. Zdrowie postrzega się w kontekście czynników psychospołecznych, gdyż wiadomo, że z każdą chorobą wiążą się silne emocje, zależne od wielu czynników. Odpowiednie wsparcie może wyzwolić motywację i energię do walki z chorobą. Problemu kryzysu i walki z nim nie doceniano w przeszłości, chociaż kryzys – jako zjawisko rozpatrywane w sferze funkcjonowania człowieka – jest nieuchronną konsekwencją rzeczywistości, w jakiej się znajdujemy. O sposobie walki z kryzysem decyduje wiele czynników: indywidualne reakcje, otoczenie, okoliczności. Autor chciałby, aby zasygnalizowane problemy stały się przyczynkiem do dyskusji nad próbą „humanizacji świata”, której nie uda się osiągnąć bez udziału nas, psychologów, a więc humanistów.
EN
Background: A routine follow-up is standard medical practice in patients treated for gynecologic cancer. Objectives of the follow-up are: 1) to detect recurrence as soon as possible and therefore improve the survival of patients with recurrence; 2) to diagnose complications related to treatment; 3) to provide psychological support and 4) to participate in scientific studies. The aim of our study was to compare the survival differences between asymptomatic and symptomatic patients at the time of relapse. Method: Retrospective cohort analysis. Results: All women diagnosed and treated for vulvar, cervical, endometrial and ovarian cancer at our institution between 2003 and 2012 were included in this retrospective study. We identified 59 patients with vulvar cancer, 216 with cervical cancer, 311 with endometrial cancer and 177 with ovarian cancer. The median survival time after recurrence between symptomatic and asymptomatic patients was in vulvar cancer 22 vs. 27 months (p = 0.181), in cervical cancer 10 vs. 13 months (p = 0.123), in endometrial cancer 19 vs. 30 months (p = 0.265) and in ovarian cancer 19 vs. 18 months (p = 0.861). Conclusions: There was no survival difference between asymptomatic and symptomatic patients at the time of relapse. Follow-up may become effective if the procedures are adapted to other aims of routine practice (e.g. psychosocial care and monitoring adverse effects of treatment). The development of follow-up care is a dynamic process, especially in the light of the continuous development of new medical technologies.
PL
Wstęp: Rutynowe badania kontrolne to procedury standardowe u pacjentek leczonych z powodu nowotworów ginekologicznych. Celem obserwacji jest: 1) jak najwcześniejsze wykrycie nawrotu i związana z tym poprawa przeżywalności pacjentek; 2) rozpoznanie powikłań związanych z leczeniem; 3) zapewnienie wsparcia psychologicznego oraz 4) prowadzenie badań naukowych. Celem niniejszej pracy było porównanie przeżywalności u pacjentek z objawami i bez objawów w czasie wznowy choroby nowotworowej. Metoda: Retrospektywne badanie kohortowe. Wyniki: Do badania retrospektywnego włączono wszystkie kobiety, u których rozpoznano i które leczono z powodu raka sromu, szyjki macicy, endometrium lub jajnika w naszym ośrodku w latach 2003–2012. Raka sromu stwierdzono u 59, raka szyjki macicy u 216, raka błony śluzowej trzonu macicy u 311, a raka jajnika u 177 pacjentek. Odpowiednio dla pacjentek z objawami i bez objawów mediana przeżycia po rozpoznaniu nawrotu wynosiła 22 vs 27 m iesięcy ( p = 0,181) w przypadku raka sromu, 10 vs 13 m iesięcy ( p = 0,123) w przypadku raka szyjki macicy, 19 vs 30 miesięcy (p = 0,265) w przypadku raka endometrium oraz 19 vs 18 miesięcy (p = 0,861) w przypadku raka jajnika. Wnioski: Nie wykazano różnic w przeżywalności między pacjentkami z objawami i bez objawów w czasie wznowy choroby nowotworowej. Obserwacja może być skuteczna, gdy jej procedury dostosowane są do innych celów postępowania rutynowego (np. opieki psychologicznej i monitorowania objawów niepożądanych związanych z leczeniem). Doskonalenie okresu obserwacji jest procesem dynamicznym, szczególnie w świetle ciągłego rozwoju nowych technologii medycznych.
first rewind previous Page / 1 next fast forward last
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.